Quarterly report · Q1

Period2023-12-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥13.4bn2023-12-01 → 2024-02-29Cons.Net sales
Revenue¥52.0bn2022-12-01 → 2023-11-30Cons.Net sales (5-year summary)
Revenue¥12.8bn2022-12-01 → 2023-02-28Cons.Net sales
Operating income¥454m2023-12-01 → 2024-02-29Cons.Operating income
Operating income−¥93m2022-12-01 → 2023-02-28Cons.Operating income
Ordinary income¥480m2023-12-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.4bn2022-12-01 → 2023-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income−¥64m2022-12-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥393m2023-12-01 → 2024-02-29Cons.Income before income taxes
Profit before tax−¥86m2022-12-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥249m2023-12-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-12-01 → 2023-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥207m2022-12-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥249m2023-12-01 → 2024-02-29Cons.Profit loss
Net income−¥208m2022-12-01 → 2023-02-28Cons.Profit loss
Total assets¥65.9bnat 2024-02-29Cons.Assets
Total assets¥67.3bnat 2023-11-30Cons.Assets
Total assets¥63.6bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥37.2bnat 2024-02-29Cons.Liabilities
Total liabilities¥38.7bnat 2023-11-30Cons.Liabilities
Net assets / equity¥28.7bnat 2024-02-29Cons.Net assets
Net assets / equity¥28.6bnat 2023-11-30Cons.Net assets
Net assets / equity¥26.5bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥4.7bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥6.9bnat 2023-11-30Cons.Cash and deposits
EPS (basic)¥6.322023-12-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.472022-12-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.252022-12-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
Equity ratio43.3%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio42.3%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio41.5%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 61
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-12-01 → 2024-02-29¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-12-01 → 2024-02-29¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-12-01 → 2024-02-29−¥31m
Reconciling Itemsreconcilingrevenue2023-12-01 → 2024-02-29−¥505m
Reconciling Itemsreconcilingrevenue intersegment2023-12-01 → 2024-02-29−¥505m
Reconciling Itemsreconcilingsegment profit2023-12-01 → 2024-02-29¥22m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue2023-12-01 → 2024-02-29¥5.9bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue external2023-12-01 → 2024-02-29¥5.5bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥371m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentsegment profit2023-12-01 → 2024-02-29¥76m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2023-12-01 → 2024-02-29¥3.0bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2023-12-01 → 2024-02-29¥3.0bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥14m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2023-12-01 → 2024-02-29¥93m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue external2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥20m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentsegment profit2023-12-01 → 2024-02-29¥112m
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue external2023-12-01 → 2024-02-29¥2.4bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥100m
jpcrp040300-q1r_E02585-000Medicalreportable segmentsegment profit2023-12-01 → 2024-02-29¥182m
—segment totalrevenue2023-12-01 → 2024-02-29¥13.9bn
—segment totalrevenue external2023-12-01 → 2024-02-29¥13.4bn
—segment totalrevenue intersegment2023-12-01 → 2024-02-29¥505m
—segment totalsegment profit2023-12-01 → 2024-02-29¥463m
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-02-29¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-02-29¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-12-01 → 2024-02-29¥505m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-02-29¥432m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-12-01 → 2023-02-28¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-12-01 → 2023-02-28¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-12-01 → 2023-02-28¥55,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-12-01 → 2023-02-28−¥23m
Reconciling Itemsreconcilingrevenue2022-12-01 → 2023-02-28−¥429m
Reconciling Itemsreconcilingrevenue intersegment2022-12-01 → 2023-02-28−¥429m
Reconciling Itemsreconcilingsegment profit2022-12-01 → 2023-02-28¥60m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue2022-12-01 → 2023-02-28¥4.9bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue external2022-12-01 → 2023-02-28¥4.6bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥341m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentsegment profit2022-12-01 → 2023-02-28¥26m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2022-12-01 → 2023-02-28¥4.2bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2022-12-01 → 2023-02-28¥4.2bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥10m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2022-12-01 → 2023-02-28−¥42m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥17m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentsegment profit2022-12-01 → 2023-02-28−¥105m
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥61m
jpcrp040300-q1r_E02585-000Medicalreportable segmentsegment profit2022-12-01 → 2023-02-28−¥9m
—segment totalrevenue2022-12-01 → 2023-02-28¥13.2bn
—segment totalrevenue external2022-12-01 → 2023-02-28¥12.8bn
—segment totalrevenue intersegment2022-12-01 → 2023-02-28¥429m
—segment totalsegment profit2022-12-01 → 2023-02-28−¥130m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-02-28¥13.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-02-28¥12.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-12-01 → 2023-02-28¥429m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-02-28−¥153m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1372000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember13214718000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-429276000JPY
Net salesPrior1YTDDuration12785442000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E02585-000FineChemicalsReportableSegmentsMember25618000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember-41907000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E02585-000MedicalReportableSegmentsMember-9210000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E02585-000IndustrialChemicalsReportableSegmentsMember-104685000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember-130183000JPY
Operating incomePrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-23051000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember-153235000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember60305000JPY
Operating incomePrior1YTDDuration-92929000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E02585-000FineChemicalsReportableSegmentsMember5512471000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember2980533000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E02585-000MedicalReportableSegmentsMember2399842000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E02585-000IndustrialChemicalsReportableSegmentsMember2529202000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember13422050000JPY
Revenues from external customersCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember4446000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember13426497000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersCurrentYTDDuration13426497000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E02585-000FineChemicalsReportableSegmentsMember371171000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember14280000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E02585-000MedicalReportableSegmentsMember100090000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E02585-000IndustrialChemicalsReportableSegmentsMember19501000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember505042000JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember505042000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-505042000JPY
Transactions with other segmentsCurrentYTDDuration-JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E02585-000FineChemicalsReportableSegmentsMember5883642000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember2994814000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E02585-000MedicalReportableSegmentsMember2499932000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E02585-000IndustrialChemicalsReportableSegmentsMember2548703000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember13927092000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember4446000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember13931539000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-505042000JPY
Net salesCurrentYTDDuration13426497000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E02585-000FineChemicalsReportableSegmentsMember75558000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember93382000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E02585-000MedicalReportableSegmentsMember182248000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E02585-000IndustrialChemicalsReportableSegmentsMember112267000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember463457000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-31311000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember432145000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember22350000JPY
Operating incomeCurrentYTDDuration454495000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-11-30pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-12-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-12-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-11-30pass
statement vs summary · total assetsconsolidated 2024-02-29pass